ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,668 | -74.2% | 43,000 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $21,930 | -19.0% | 43,000 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $27,090 | -2.9% | 43,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $27,911 | -72.4% | 43,000 | -26.7% | 0.00% | -71.4% |
Q3 2022 | $101,000 | +53.0% | 58,700 | +10.9% | 0.01% | +75.0% |
Q2 2022 | $66,000 | +112.9% | 52,950 | +10.3% | 0.00% | +100.0% |
Q1 2022 | $31,000 | -40.4% | 48,000 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $52,000 | -40.2% | 48,000 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $87,000 | -31.5% | 48,000 | 0.0% | 0.01% | -33.3% |
Q2 2021 | $127,000 | -26.6% | 48,000 | 0.0% | 0.01% | -25.0% |
Q1 2021 | $173,000 | +43.0% | 48,000 | 0.0% | 0.01% | +20.0% |
Q4 2020 | $121,000 | 0.0% | 48,000 | 0.0% | 0.01% | -9.1% |
Q3 2020 | $121,000 | -22.9% | 48,000 | 0.0% | 0.01% | -26.7% |
Q2 2020 | $157,000 | +33.1% | 48,000 | 0.0% | 0.02% | +15.4% |
Q1 2020 | $118,000 | -53.9% | 48,000 | +102.1% | 0.01% | -72.3% |
Q1 2015 | $256,000 | +113.3% | 23,752 | 0.0% | 0.05% | +104.3% |
Q4 2014 | $120,000 | – | 23,752 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
SFMG, LLC | 62,433 | $334,000 | 0.07% |
Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |